This study aimed to determine the relationship of serum adiponectin and resistin levels with the severity of liver fibrosis in patients with chronic hepatitis B (CHB), depending on the duration of antiviral therapy. This evidence concerns the gene ADIPOQ and chronic hepatitis B virus infection.